News|Articles|June 6, 2024

Infection Control Today

  • Infection Control Today, July/August 2024 (Vol 28 No.4)
  • Volume 28
  • Issue 4

Tampa General Hospital's Success in Eliminating Bloodstream Infections in ECMO Patients

Tampa General Hospital's ECMO-specific infection prevention protocol eradicated bloodstream infections, reducing rates from 36% to 0%, demonstrating the effectiveness of tailored infection control measures in high-risk patients.

Tampa General Hospital (TGH), a leading tertiary care academic medical center, has successfully eradicated bloodstream infections (BSIs) in patients undergoing extracorporeal membrane oxygenation (ECMO) within their 18-bed cardiothoracic intensive care unit (CTICU).

This achievement was showcased in a presentation titled “Bundled Approach to Reduce Bloodstream Infections in Patients Requiring Use of Extracorporeal Membrane Oxygenation” at the 2024 Association for Professionals in Infection Control and Epidemiology (APIC) Annual Conference & Exposition in San Antonio, Texas, held from June 3 to 5. There, TGH representatives reported a reduction in ECMO-related BSI rates from 36% in October 2021 to 0% in April 2022. This zero-infection rate was sustained for 7 months, with the hospital maintaining a 4-month streak of no infections.

To find out how that reduction was accomplished, Infection Control Today® (ICT®) spoke with the authors of the study, all of whom work for Tampa General Hospital: Mini Radhakrishnan, BSN, RN, CIC, the infection preventionist, and Kimberly E. Atrubin, MPH, CIC, CPHQ, FAPIC, the infection prevention director. The other authors were Carmen M. Murphy, MSN, RN, CIC, FAPIC, the infection prevention manager, and Lauren Wojciechowski, DNP, AGACNP-BC, nurse practitioner.

“When we did our literature review, we did find that there was no standardized protocol underlying care of ECMO patients,” Radhakrishnan told ICT. “There were protocols in place somewhat aligned to central line bloodstream infection, but they did not customize to the patient's need. In our facility during the [COVID-19] era, we noticed a high spike in bloodstream infections; it rose to about 36% in October [2021].”

The team did a literature review to focus on ECMO patients and the bloodstream infections they get. “We found so many environmental clinical risk factors underlining patients,” Radhakrishnan explained. “So, amalgamating all that and the patient's risk factors, we came up with a management approach to reduce ECMO. And that is my presentation today.”

The authors emphasized that they did not reach their goal of no infections without teamwork. “Really big kudos to [Radhakrishnan] for even identifying the fact that we had several bloodstream infections,” Atrubin said. “And to even go down this pathway because it's not a traditional element of surveillance. So, it's not something that we have to report nationally through the National Healthcare Safety Network (NHSN). So, this could easily be something that gets lost in routine infection prevention departments. So, for her even identifying that this was an issue in our unit, and then having to kind of work through that process [of] working with the team and collaborating with them, and coming up with a tool that would help us improve [the issue] was outstanding work.”


Related to this article

Dyan Troxell, MSN, RN, director of clinical education at HandCraft Linen Services; J.J. Odom, MBA, CHESP, CMIP, T-CHEST, university director of buildings and grounds for UConn Health and chair-elect of the AHE Board; and Jenna Rivers, MPH, CPH, CIC, manager of infection prevention and control at Moffitt Cancer Center in Tampa, Florida.
At AHE Exchange 2026, ICT spoke with experts representing commercial laundry services, EVS, and infection prevention about the systems behind a successful reusable linen program. They discuss linen quality, reject rates, unnecessary waste, frontline education, data, PAR levels, infection prevention oversight, and why strong relationships between health care facilities and their laundry providers matter.
Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)
Can a UV-C robot make up for a surface that wasn't properly cleaned? Experts say that's the wrong way to think about the technology. UV-C can provide an additional layer of microbial reduction, but factors including shadows, distance, positioning, and exposure time mean it cannot replace thorough manual cleaning and disinfection.
Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)
During an expert panel at Exchange26 on whole-room microbial reduction technologies, regulatory and health care leaders discussed the distinction between FDA and EPA oversight, what constitutes a medical device claim, the risks surrounding unauthorized or off-label claims, and why IP and EVS professionals should verify a device's regulatory status rather than relying solely on vendor presentations.
Donald Sipp, Jr, MBA, RESE, CHESP, CHTI-2, CMIP, PMP, and David Green  (Image credit: author)
“Cutting” waste shouldn’t mean cutting people. At AHE Exchange26, David Green and Donald Sipp explored how EVS departments can improve performance by strengthening workplace culture, empowering employees, eliminating inefficient processes, and understanding EVS’s critical role in patient throughput. One case study showed bed turnaround times falling from nearly 2 hours to less than an hour, but the larger lesson wasn't simply about speed. High-performing EVS operations begin with a strong foundation.